Childrens Robitussin Honey Cough (Glaxosmithkline) – Defective Dosing Cup (2020)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.
Brand
Glaxosmithkline Consumer Healthcare Holdings
Lot Codes / Batch Numbers
Lot #s: 02177, 02178, Exp. 01/31/2022
Products Sold
Lot #s: 02177, 02178, Exp. 01/31/2022
Glaxosmithkline Consumer Healthcare Holdings is recalling Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guai due to Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026